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ABSTRACT
Background: Infertility is a major cause of social and psychological problems among couples, especially in our environment 
where child bearing is regarded as one of the major reasons for marriage. Studies have shown that fertility among human 
immunodeficiency virus (HIV)‑infected women may actually be reduced posing social and psychological disturbance among 
a group of people that are already burdened with disease.
Objective: The aim of the study was to determine the prevalence and clinical correlates of HIV infection among women with 
infertility attending a gynecology clinic in northwestern Nigeria.
Materials and Methods: It was a cross‑sectional descriptive study comprising of women attending the gynecology clinic 
due to infertility that satisfied the inclusion criteria. The sample size was 250. Ethical clearance was obtained from the health 
research and ethics committee of the study setting. Clients were recruited consecutively as they presented to the infertility 
clinic from May 2015 to January 2016 and tested for HIV infection. HIV testing was done in the Department of Medical 
Microbiology after collecting 5 ml of blood from the clients using sterile syringes. Investigations to determine the cause of 
infertility were also conducted. Obtained data were analyzed using Statistical Package for Social Science version 20.0.
Results: A total of 250 clients were recruited for the study. The age range of respondents was‑ 17 – 47 years with a mean 
age of 30.3 years. Hausa was the predominant ethnic group in all respondents (61%). Most of the respondents had secondary 
education (39%). Only 4% had postgraduate education. Out of the 250 respondents, 21 (8.4%) were found to be positive for 
HIV infection. Chi‑square test showed an association between tuboperitoneal infertility and HIV infection.
Conclusion: The prevalence of HIV infection in women with infertility attending our clinic was high and an association was 
seen between HIV infection and tuboperitoneal infertility.
Key words: Clinical correlates; human immunodeficiency virus infection; infertility.
Introduction
Human immunodeficiency virus (HIV) infection is a pandemic 
that has altered the morbidity and mortality patterns of many 
medical conditions. It is also a major cause of social and 
psychological problem among infected individuals, their families 
and the community at large. Currently, there are about 36.7 
million people living with HIV infection worldwide.[1] Majority of 
the people living with HIV infection are in sub-Saharan Africa.[1]
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Infertility affects 3.5%–16.7% of couples worldwide.[2] 
Infertility also leads to social and psychological problems 
especially in environments where child bearing determines 
the position of a woman in the family and society at large. 
However, infertility is often neglected as a health problem 
of public importance as it is perceived to be the couples’ 
problem.[3]
HIV infection has been associated with both male and female 
factor infertility. Interplay of several biological and social 
factors has been identified as possible linkage between 
HIV infection and infertility.[4] Age, marital status, coital 
frequency, use of contraception, and presence of other 
sexually transmitted infections can all affect fertility in HIV 
infected individuals. It has also been argued that women with 
fertility problems are at increased risk of marital instability 
and, therefore, HIV infection; consequently, preexisting 
subfertility among HIV infected women may contribute to 
the observed association.[5]
Even though social and behavioral factors have been 
implicated in the decreased fertility seen in HIV-infected 
women in the sense that they may not desire more children 
due to the fear of dying and leaving them with no care and 
support,[6] Oladapo et al.[7] reported that infertile HIV positive 
women were still desirous of having more children. In a study 
on fertility desires and intensions of HIV positive patients 
at a suburban specialist center, only 4.3% of women who 
desired children before finding out their HIV status did not 
intend to have any afterward.[7] Fabiani et al.[8] also argued 
that social factors play a minor role in infertility among 
HIV-positive women.
Studies have revealed a wide variability in the prevalence of 
HIV infection among infertile couples ranging from 0.3% as 
reported by Balasch et al.[9] in an infertility clinic in Barcelona 
to 18% as seen in Tanzania.[10] Prevalence rate of up to 20% 
was reported in a study from South Africa.[11] Favot et al.[10] 
in a study on HIV and sexual behavior among women with 
infertility in Tanzania reported that prevalence of HIV 
infection was higher among clients with infertility (18.2%) 
as compared to fertile women (6.6%). In Gabon, Western 
equatorial Africa, the seroprevalence of HIV 1 infection 
among clients with both primary and secondary infertility 
was reported to be 9.3% by Schrijvers et al.,[12] while 
prevalence of primary and secondary infertility among 
non-HIV-infected clients was reported as 0.7% and 2.1% 
respectively in the same setting.
Despite the observed differences in the prevalence rate of 
HIV infection among fertile and infertile women, the surveys 
conducted to estimate the prevalence of infertility in many 
countries are conducted on antenatal attendees thus women 
with infertility are not part of the surveys. The prevalence 
of HIV infection among women attending antenatal clinic 
is generally considered to be the prevalence of infection 
among adult women population and the general population 
at large.[13] This may not reflect the true prevalence in the 
community because infertile women are excluded from 
such estimates countries.[14] Thus, there is need to know the 
prevalence of HIV infection among couples with infertility. 
This will determine whether the burden of HIV infection 
among clients with infertility is enough for a policy of routine 
screening or at least group counseling and opt out method 
to be adopted in infertility clinic in our center as practiced 
in our antenatal clinic.
Different factors may lead to infertility among HIV-infected 
couples ranging from lower fertility rates, increased tubal 
disease, anovulation to abnormal semen parameters.[15-19]
The aim of this study was to determine the prevalence of HIV 
infection and clinical correlates among clients with infertility.
Materials and Methods
A total of 250 out of 278 women who presented for evaluation 
for infertility at the gynecology clinic between 1st May 2015 
and 31st January 2016 were recruited to participate in the 
study. The sample size was determined by the Fisher’s 
formula for calculating sample size in cross-sectional studies. 
Prevalence of 18.2% obtained from study by Favot et al.[10] 
was used to calculate the sample size. The level of precision 
was set at 5% (0.05). Ethical clearance was obtained from the 
Health Research and Ethics Committee.
Clients were counseled for HIV test using the ‘opt out’ 
technique. A written informed consent was obtained. Blood 
sample (5 ml) was obtained into a vacutainer specimen bottle 
using aseptic technique. Patients that were known to be HIV 
positive were not tested again. After collection, the sample 
was centrifuged at 5000 revolutions per minute for 5 min to 
separate blood cells from serum. The serum was then used to 
detect the presence of HIV antibodies using Alere Determine 
HIV-1/2 test kit by Abbot.[20] The HIV (1 + 2) Ag&Ab ELISA 
test kit by Chemux Bioscience Inc.[21] was used to confirm 
positive results. The HIV test was done in the Department 
of Medical Microbiology Ahmadu Bello University Teaching 
Hospital Shika. Partner counselling and testing was also done 
for HIV-positive women.
Investigations to determine the cause of infertility included 
a pelvic scan, hormonal profile, seminal fluid analysis, and 
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hysterosalpingogram. A questionnaire was used to obtain 
information on sociodemographic data, reproductive profile, 
infertility profile, and HIV profile.
The data obtained were analyzed with Statistical Package 
for Social Science version 20.0. Chi-square test was done to 
determine association between HIV infection and type of 
infertility. The confidence interval was set at 95% with P value 
of 0.05. Thus, statistical significance is P < 0.05.
Results
A total of 250 clients were recruited for the study. The age 
range of respondents was 17–47 years with a mean age of 
30.3 (SD 6.3) years. Hausa was the predominant ethnic group 
in all respondents (61%). Most of the respondents had tertiary 
education (39%). Only 4% had postgraduate education.
Out of the 250 respondents, 21 (8.4%) were found to have 
HIV 1 and/or II antibodies. A total of 14 HIV-positive clients 
were already aware of their HIV status, while seven clients 
were newly diagnosed. Most HIV-positive clients (42.9%) were 
within the 35–39 year age range. None was below 20 years of 
age. Hausa is the predominant ethnic group in HIV-positive 
clients (52.3%). Most of the HIV-positive clients had secondary 
education (28.6%). Only 9.5% of the HIV-positive clients had 
postgraduate education.
History of at least one-term pregnancy and one live birth 
was reported in 52.4% and 42.9% of HIV-positive women, 
respectively.
History of multiple sex partners was 85.7% HIV-positive clients 
and 76.2% had never used condom in the past. They also had 
history of reproductive tract infection (71.4%). History of 
blood transfusion was present in 33.3% of the HIV-positive 
clients and 4.8% of their partners, respectively.
Secondary infertility was the commonest (81%) type of 
infertility seen in HIV-positive clients. Tuboperitoneal factor 
infertility was seen in 71.4% of HIV-positive clients. Polycystic 
ovarian syndrome (PCOS) was seen in 14.2% of the clients. 
Uterine factor and male factor infertility were each seen 
9.5% of the clients. Only 4.8% of the clients were reported 
to have hyperprolactinemia as a cause of infertility. Some of 
HIV-positive clients (9.5%) had more than one documented 
cause of infertility. Tuboperitoneal factor was the only 
cause of infertility that was significantly associated with HIV 
infection (95% confidence interval, P = 0.048).
Serodiscordance was seen in 42.9% of HIV-positive women. 
Majority of the HIV-positive clients (90.5%) were diagnosed 
within the last 10 years. Most of the HIV-positive clients 
were diagnosed with HIV after they have been diagnosed 
with infertility. Most of the clients (52.4%) were at stage II 
HIV disease and 66.7% of the clients are on highly active 
antiretroviral therapy (HAART).
Discussion
The sociodemographic characteristics of HIV positive clients 
with infertility are similar to HIV-negative clients with 
infertility in this study [Table 1]. Generally, the age-specific 
fertility rates of HIV-positive women are said to be reduced 
as compared to uninfected women except for those in the 
15–19-year age range where fertility is said to be higher based 
on reports from many countries.[22] This may account for the 
fact that even though infertility cuts across all reproductive 
age groups among clients that are HIV negative, none of the 
HIV-positive clients was within the 15–19-year age bracket. 
The distribution of clients based on their tribes is similar in 
both HIV-positive and HIV-negative clients and this reflects 
what is obtained in Zaria generally. More than 80% of the 
HIV-positive clients had some form of western education. 
Islamic education, which is sometimes taught in Arabic, was 
the only form of education attained by 19% of the clients. This 
may be accounted for by the fact that even though Zaria is 
a predominantly Muslim community, it has a long history of 
Western colonization and considered as a center of learning. 
There was no significant statistical association between age, 
tribe, and level of education with HIV status.
The prevalence of HIV infection among clients with infertility 
was found to be 8.4%. This is lower than the values reported 
from Gabon (9.3%), Tanzania (18.2%), and South Africa (20%). 
In Gabon and South Africa, the national prevalence of HIV 
infection is higher than the national prevalence in our setting. 
Despite the fact that the prevalence of HIV infection among 
women infertility in our study (8.4%) appears to be lower 
than that observed in Gabon (9.3%) and South Africa(20%), 
the burden may still be significant when compared to our 
national prevalence of HIV infection.
The prevalence of HIV infection among women with infertility 
in our clinic is double the national prevalence of 4.1% and 
also higher than the prevalence of 5.1% in our state.[23] This 
is similar to findings in other African countries where the 
prevalence of HIV infection among clients with infertility 
was found to be generally higher than the prevalence of HIV 
infection in the general population. In Tanzania, prevalence of 
18.2% was reported among clients with infertility as compared 
to 6.6% among fertile women.[10] In Gabon, the national 
prevalence of HIV infection is 3.8%,[1] while prevalence of 
HIV infection among clients with infertility is 9.3%.[12] In 
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South Africa the national prevalence of HIV infection is 
19.1%,[1] while the prevalence of HIV infection among clients 
with infertility is 20%. In all these countries, the prevalence 
of HIV infection is derived from the antenatal attendees. 
This means that women with infertility were not included 
in the estimates. Couples with infertility constitute about 
3.5%–16.7%[2] of the general population. The fact that the 
prevalence of HIV infection among these group of women 
differ significantly raises concern with regards to the ability 
of antenatal deduction of the prevalence of HIV infection to 
accurately estimate the true prevalence of the infection in 
the general population.
Conflicting literature has been published by different 
authors in different countries with this regard. Although 
some authors reported that antenatal surveillance of HIV 
infection closely relates to the estimates observed in the 
general population,[2] some reported that it underestimates 
the population based estimates[24] and others reported that 
it overestimates the true population estimates.[25] Thus, 
there is need for population-based studies in each country 
to actually estimate the prevalence of HIV infection in the 
general population which will help in policy making and 
also assessing the measures put in place to combat this 
pandemic.
The reproductive profile of HIV positive clients may suggest 
pregnancy-related complications and possible perinatal and 
infant mortality. The number of term pregnancies among the 
HIV positive clients was higher than the number of live births. 
They also had a higher number of live births than number of 
surviving children. It has been documented in the literature 
that complications of pregnancy are said to be commoner 
among HIV-positive women leading to overall lower births 
rates among them.[26-28] Also, HIV-exposed infants have a high 
perinatal and infant mortality rates.[29,30]
Many of the HIV-positive clients (85%) had a history of multiple 
sexual partners and 76.2% had never used condoms. This is 
in keeping with the fact that having multiple sexual partners 
is a strong predictor of risk of HIV infection.[31] Other risk 
factors include use of blood transfusion which was positive 
in 33.3% of HIV-positive clients and 4.8% of their partners.
Secondary infertility is the commonest type of infertility seen 
in 81% of HIV-positive clients. This pattern is seen globally.[3] 
Tuboperitoneal factor was the commonest cause of infertility 
seen in 81% of HIV-positive clients and the association 
between tuboperitoneal infertility and HIV infection was 
statistically significant (95% confidence interval, P = 0.048) 
[Table 2]. This is in keeping with what has been reported 
by researchers in sub-Saharan Africa.[16,17,32] Tuboperitoneal 
infertility which is the commonest type of infertility seen in 
the so called infertility belt of Africa has been associated with 
HIV infection by other authors. Adegoke et al.[16] reported 
that tuboperitoneal abnormalities were more common 
among infertile women infected with HIV as compared to 
those without HIV infection. Adesiyun et al.[17] in a study on 
hysterosalpingographic tubal abnormalities and HIV infection 
among black women with tubal infertility in sub-Saharan 
Africa reported higher incidence of tubal disease among 
women infected with HIV compared with their counterparts. 
The association between HIV infection and tuboperitoneal 
infertility may not differ from the association between 
reproductive tract infection and infertility. It may also coexist 
with other sexually transmitted infections like chlamydia 
and gonorrhea which are known causes of tuboperitoneal 
infertility. Moreover, presence of other sexually transmitted 
genital tract infections is known to facilitate HIV transmission.
PCOS was seen in 14.2% of the clients, while 4.8% of the 
clients were reported to have hyperprolactinemia as a cause 
of infertility. Endocrine factor has also been implicated as 
a cause of infertility among HIV-positive women. This is 
supported by the fact that anovulation and amenorrhea are 
associated with HIV infection.[18] Antiretroviral drugs have 
also been associated with lipodsytrophy characterized by fat 
redistribution, insulin resistance, dyslipidemia, and increased 
Table 1: Sociodemographic profile of participants
Profile HIV positive HIV negative P
Frequency Percentage Frequency Percentage
Age 
15‑19 0 0 20 8.7 0.108
20‑24 1 4.8 26 11.4
25‑29 4 19 92 40.2
30‑34 5 23.8 38 16.6
35‑39 9 42.9 31 13.5
40‑44 2 9.5 16 7
45‑49 0 0 6 2.6
Total 21 100 229 100
Tribe
Hausa 11 52.3 143 62.4 0.891
Yoruba 2 9.5 18 7.8
Igbo 0 0 6 2.6
Kataf 5 23.8 21 9.2
Others 3 14.2 41 17.9
Total 21 99.9 229 99.9
Highest level of 
education
Primary 5 23.8 22 9.6 0.069
Secondary 6 28.6 78 34.1
Tertiary 4 19.0 94 41.0
Post graduate 2 9.5 8 3.5
Islamic education 4 19.0 27 11.7
Total 21 99.9 229 99.9
*Statistically significant P<0.005
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luteinizing hormone follicle-stimulating hormone ratio, thus 
producing a picture similar to PCOS.[33] Premature ovarian 
failure has also been associated with HIV infection leading 
to infertility with elevated follicle-stimulating hormone 
mimicking a menopausal state. Clark et al.[34] reported the 
incidence of anovulation and early menopause of 8% among 
a clinical trial group. However, larger studies did not agree 
with this theory.[18,35] This study did not demonstrate any 
statistically significant association between HIV infection 
and anovulatory infertility (P value; PCOS = 0.059 and 
hyperprolactinemia = 0.861) [Table 2].
Male factor infertility was documented in 9.5% of the 
clients. Male factor infertility is also a recognized cause 
of infertility among HIV-infected couples as HIV infection 
has been associated with decrease semen volume, sperm 
motility, and concentration and abnormal morphology.[19] The 
damage to sperm cells has been attributed to HAART rather 
than the disease process itself.[36] However, some authors 
argue that HAART does not affect semen parameters.[37] 
Semen parameters are said to correlate with CD4 count. 
Nicopoullos et al. reported that use of HAART is associated 
with decrease total sperm count, progressive motility, and 
postpreparation count while significantly increasing the 
proportion of abnormal sperm forms following experience 
from a decade of sperm washing.[38] Androgen insufficiency, 
hypogonadism, low testosterone (gonadal and extragonadal), 
diminished libido, and impotence are all documented causes 
of male infertility.[39] Tindall et al.[40] reported prevalence of 
impotence to be as high as 60% among males with advance 
disease. Other drugs used commonly in HIV-positive 
patients like glucocorticoids and ketoconozole may produce 
side effects that may impair fertility. These drugs cause 
suppression of the hypothalamopituitarygonadal axis leading 
to low testosterone.[41] This study did not demonstrate any 
significant association between male factor infertility and 
HIV infection ( = 0.762) [Table 2].
Some of HIV-positive clients (9.5%) had more than one 
documented cause of infertility. This may be due to interplay 
of many factors.
Serodiscordance was seen in 42.9% of HIV-positive couples. 
This is of significance in view of possibility of horizontal 
transmission of the virus and also fertility treatment options. 
Fertility treatment options include timed unprotected 
intercourse, intrauterine insemination of sperm, in-vitro 
fertilization, and adoption. In the same context, there may 
be need to screen male partners of all clients with infertility 
irrespective of the HIV serostatus of the female partner. This 
is important in view of choosing a fertility treatment option 
that will eliminate or minimize risk of horizontal as well as 
vertical transmission of HIV infection.
Most of the HIV-positive women (52.4%) were in stage II of the 
disease and none progressed to acquired immunodeficiency 
syndrome (AIDS). Duration of the disease among clients 
that were already known to be HIV positive was less than 
10 years in 90.5% of clients. This means that they were 
within the latency period. Even though 9.5% of the clients 
were more than 10 years postdiagnosis of HIV infection, 
use of antiretroviral therapy prevents progression to AIDS 
after 10 years of disease as seen in the natural history of 
the disease without intervention. Most of the HIV positive 
clients (66.7%) were already on antiretroviral therapy. This 
may explain the reason why none of the clients were in the 
advanced stage of the disease.
Conclusion
The prevalence of HIV infection among women with infertility 
is much higher than the national prevalence deducted from 
antenatal attendees. Thus, the deduction from antenatal 
women may not be representative of the actual prevalence 
in the general population.
Table 2: Association between HIV status and Infertility
Infertility profile HIV Positive Negative P
Frequency Percentage Frequency Percentage
Duration of infertility 14 66.7 126 55 0.169
<5 years 7 33.3 103 45
≥5 years 21 100 229 100
Cause of infertility
Tuboperitoneal 15 71.4 112 49.0 0.048*
Uterine 2 9.5 22 9.6 0.990
PCOS 3 14.2 79 34.5 0.059
Hyperprolactinemia 1 4.8 13 5.7 0.861
Male factor 2 9.5 23 10.0 0.939
Endometriosis 0 0 1 0.4 0.762
Multiple factors 2 9.5 2 9.2 ‑
*Statistically significant = P<0.005
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The sociodemographic characteristics and causes of infertility 
were similar among both the HIV-positive and-negative 
clients. Tuboperitoneal infertility was the commonest cause 
of infertility in our clients and was significantly associated 
with HIV infection. The major drawback of this study is 
the fact that only characteristics of few patients have been 
presented; thus, it may not reflect the overall association 
between HIV infection and infertility.
Recommendations
There is need to screen all infertile couples for HIV infection. 
Studying the prevalence of infertility among HIV-positive 
clients may provide more information about the association 
between HIV infection and infertility. There is also need to 
study the prevalence of HIV in the general population in order 
to make appropriate policies that will help in combating the 
pandemic because deduction from antenatal attendees may 
not actually be accurate in estimating the burden of the 
disease in the general population.
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